These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11217318)

  • 1. Antibodies to MMP-cleaved aggrecan.
    Fosang AJ; Last K; Jackson DC; Brown L
    Methods Mol Biol; 2001; 151():425-49. PubMed ID: 11217318
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of antibodies against degradative neoepitopes in aggrecan.
    Mort JS; Roughley PJ
    Methods Mol Med; 2004; 100():237-50. PubMed ID: 15280599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.
    Mort JS; Magny MC; Lee ER
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):491-4. PubMed ID: 9794785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and nonarthritogenic) autoreactive T cell hybridoma clones.
    Buzás EI; Hanyecz A; Murad Y; Hudecz F; Rajnavölgyi E; Mikecz K; Glant TT
    J Immunol; 2003 Sep; 171(6):3025-33. PubMed ID: 12960328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
    Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
    Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell cytokine responses to cartilage aggrecan in BALB/c mice.
    McKee HI; Warnock MG; Laycock C; Diamond AG; Bramwell H; Goodacre JA
    Biochem Soc Trans; 1997 May; 25(2):311S. PubMed ID: 9191355
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan.
    Fosang AJ; Last K; Stanton H; Golub SB; Little CB; Brown L; Jackson DC
    Methods Mol Biol; 2010; 622():312-47. PubMed ID: 20135291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.
    Leroux JY; Guerassimov A; Cartman A; Delaunay N; Webber C; Rosenberg LC; Banerjee S; Poole AR
    J Clin Invest; 1996 Feb; 97(3):621-32. PubMed ID: 8609216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic properties of keratan sulfate: influence of antigen structure, monoclonal antibodies, and antibody valency.
    Seibel MJ; Macaulay W; Jelsma R; Saed-Nejad F; Ratcliffe A
    Arch Biochem Biophys; 1992 Aug; 296(2):410-8. PubMed ID: 1378715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.
    Sandy JD; Thompson V; Doege K; Verscharen C
    Biochem J; 2000 Oct; 351(Pt 1):161-6. PubMed ID: 10998358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.